In addition, in the study of ERCC1 in postoperative non-small cell lung cancer, it was found that the expression of ERCC1 mRNA was negatively correlated with chemotherapy efficacy and survival time of patients [52]. This evidence concerns the gene ERCC1 and non-small cell lung carcinoma.